Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis

por Papp, Maria, Tornai, Tamas, Vitalis, Zsuzsanna, Tornai, Istvan, Tornai, David, Dinya, Tamas, Sumegi, Andrea, Antal-Szalmas, Peter
Publicado 2016

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

por Tornai, David, Antal-Szalmas, Peter, Tornai, Tamas, Papp, Maria, Tornai, Istvan, Sipeki, Nora, Janka, Tamas, Balogh, Boglarka, Vitalis, Zsuzsanna
Publicado 2021

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation

por Palyu, Eszter, Harsfalvi, Jolan, Tornai, Tamas, Papp, Maria, Udvardy, Miklos, Szekeres-Csiki, Katalin, Pataki, Lajos, Vanhoorelbeke, Karen, Feys, Hendrik B., Deckmyn, Hans, Tornai, Istvan
Publicado 2018

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

por Tornai, Tamas, Tornai, David, Sipeki, Nora, Tornai, Istvan, Alsulaimani, Rayan, Fechner, Kai, Roggenbuck, Dirk, Norman, Gary L., Veres, Gabor, Par, Gabriella, Par, Alajos, Szalay, Ferenc, Lakatos, Peter Laszlo, Antal-Szalmas, Peter, Papp, Maria
Publicado 2018

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

por Tornai, Tamas, Palyu, Eszter, Vitalis, Zsuzsanna, Tornai, Istvan, Tornai, David, Antal-Szalmas, Peter, Norman, Gary L, Shums, Zakera, Veres, Gabor, Dezsofi, Antal, Par, Gabriella, Par, Alajos, Orosz, Peter, Szalay, Ferenc, Lakatos, Peter Laszlo, Papp, Maria
Publicado 2017

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?

por Papp, Maria, Norman, Gary L., Vitalis, Zsuzsanna, Tornai, Istvan, Altorjay, Istvan, Foldi, Ildiko, Udvardy, Miklos, Shums, Zakera, Dinya, Tamas, Orosz, Peter, Lombay, Bela, Par, Gabriella, Par, Alajos, Veres, Gabor, Csak, Timea, Osztovits, Janos, Szalay, Ferenc, Lakatos, Peter Laszlo
Publicado 2010

IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort

por Pár, Alajos, Pár, Gabriella, Tornai, István, Szalay, Ferenc, Várszegi, Dalma, Fráter, Edit, Papp, Mária, Lengyel, Gabriella, Fehér, János, Varga, Márta, Gervain, Judit, Schuller, János, Nemes, Zsuzsanna, Péterfi, Zoltán, Tusnádi, Anna, Hunyady, Béla, Haragh, Attila, Szinku, Zsolt, Vincze, Áron, Szereday, László, Kisfali, Péter, Melegh, Béla
Publicado 2014

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy

por Hunyady, Béla, Abonyi, Margit, Gerlei, Zsuzsanna, Gervain, Judit, Horváth, Gábor, Jancsik, Viktor, Lengyel, Gabriella, Makkai, Erzsébet, Pár, Alajos, Péter, Zoltán, Pusztay, Margit, Ribiczey, Pál, Rókusz, László, Sarrazin, Christoph, Schneider, Ferenc, Susser, Simone, Szalay, Ferenc, Tornai, István, Tusnádi, Anna, Újhelyi, Eszter, Werling, Klára, Makara, Mihály
Publicado 2018